Research funds should be returned if findings can’t be reproduced, proposes Merck chiefBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2477 (Published 29 April 2016) Cite this as: BMJ 2016;353:i2477
- Susan Mayor
Universities should return funding from the industry for research that proves to be non-reproducible, the chief medical officer of the drug company Merck has said in a proposal to reduce research that cannot be replicated by others.
“Recent studies have shown that the key findings in 50% or more of published reports in certain fields cannot be reproduced,” wrote Michael …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial